Indication

Leprosy

Leprosy, also referred to as Hansen disease, is a chronic granulomatous infection primarily caused by the obligate intracellular acid-fast bacilli *Mycobacterium leprae* and *Mycobacterium lepromatosis*. Read more about Leprosy

14 drugs 14 manufacturers

Advertisement

Drugs that treat it

Common Leprosy therapies.

Showing 1–9 of 14 drugs

DAPSONE

LEPROSY·+1
Major Pharamceuticals

DAPSONE

ANTIPROTOZOAL AGENTS·LEPROSY·+1
GSK Consumer Healthcare

DAPSONE

ANTIPROTOZOAL AGENTS·LEPROSY·+1
AVKARE

DAPSONE

ANTIPROTOZOAL AGENTS·LEPROSY·+1
PROFICIENT RX L

DAPSONE

ANTIPROTOZOAL AGENTS·LEPROSY·+1
RISING PHARM
Filter & compare in the drug finder →Opens the drug finder with Leprosy preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Leprosy.

Leprosy, also referred to as Hansen disease, is a chronic granulomatous infection primarily caused by the obligate intracellular acid-fast bacilli *Mycobacterium leprae* and *Mycobacterium lepromatosis*.

The infection predominantly targets the peripheral nervous system, skin, upper respiratory tract mucosa, and eyes across susceptible human populations.

Pathophysiologically, the bacteria demonstrate a unique predilection for Schwann cells and dermal macrophages, producing clinical manifestations across an immunological spectrum ranging from tuberculoid to lepromatous disease.

Defining clinical features include hypopigmented or erythematous skin lesions exhibiting sensory impairment, peripheral nerve enlargement with sensory or motor deficits, and, in severe or progressive cases, chronic ulcerations and disabling physical deformities.

Personalize your experience

Follow Leprosy and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it